<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31797533</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity.</ArticleTitle><Pagination><StartPage>e47528</StartPage><MedlinePgn>e47528</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47528</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.201847528</ELocationID><Abstract><AbstractText>SAMHD1 possesses multiple functions, but whether cellular factors regulate SAMHD1 expression or its function remains not well characterized. Here, by investigating why cultured RD and HEK293T cells show different sensitivity to enterovirus 71 (EV71) infection, we demonstrate that SAMHD1 is a restriction factor for EV71. Importantly, we identify TRIM21, an E3 ubiquitin ligase, as a key regulator of SAMHD1, which specifically interacts and degrades SAMHD1 through the proteasomal pathway. However, TRIM21 has no effect on EV71 replication itself. Moreover, we prove that interferon production stimulated by EV71 infection induces increased TRIM21 and SAMHD1 expression, whereas increasing TRIM21 overrides SAMHD1 inhibition of EV71 in cells and in a neonatal mouse model. TRIM21-mediated degradation of SAMHD1 also affects SAMHD1-dependent restriction of HIV-1 and the regulation of interferon production. We further identify the functional domains in TRIM21 required for SAMHD1 binding and the ubiquitination site K622 in SAMHD1 and show that phosphorylation of SAMHD1 at T592 also blocks EV71 restriction. Our findings illuminate how EV71 overcomes SAMHD1 inhibition via the upregulation of TRIM21.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhaolong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huan</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jinghua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhilei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xiao-Fang</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, Ministry of Education), Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Baisong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4507-521X</Identifier><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research, Changchun, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81672004</GrantID><Agency>NSF | Foundation for Innovative Research Groups of the National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>31270202</GrantID><Agency>NSF | Foundation for Innovative Research Groups of the National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>81701987</GrantID><Agency>NSF | Foundation for Innovative Research Groups of the National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>JLUSTIRT, 2017TD-05</GrantID><Agency>JLU | Program for Jilin University Science and Technology Innovative Research Team (Program for JLU Science and Technology Innovative Research Team)</Agency><Country>International</Country></Grant><Grant><GrantID>20190101003JH</GrantID><Agency>Science and Technology Department of Jilin Province</Agency><Country>International</Country></Grant><Grant><GrantID>20102209</GrantID><Agency>Key Laboratory of Molecular Virology, Jilin Province</Agency><Country>International</Country></Grant><Grant><GrantID>JDYY82017003</GrantID><Agency>Youth Foundation of the First Hospital of Jilin University</Agency><Country>International</Country></Grant><Grant><Agency>Graduate Innovation Fund of Jilin University</Agency><Country>International</Country></Grant><Grant><GrantID>2018ZX10302104-001-010</GrantID><Agency>Chinese Ministry of Science and Technology</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="D000076106">SAM Domain and HD Domain-Containing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="C484280">SAMHD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076106" MajorTopicYN="N">SAM Domain and HD Domain-Containing Protein 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71 infection</Keyword><Keyword MajorTopicYN="N">SAMHD1 inhibition</Keyword><Keyword MajorTopicYN="N">interferon induction</Keyword><Keyword MajorTopicYN="N">regulation</Keyword><Keyword MajorTopicYN="N">ubiquitin-proteasome degradation</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31797533</ArticleId><ArticleId IdType="pmc">PMC6944907</ArticleId><ArticleId IdType="doi">10.15252/embr.201847528</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik&#x2010;Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J (2011) Vpx relieves inhibition of HIV&#x2010;1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658&#x2013;661</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179858</ArticleId><ArticleId IdType="pubmed">21720370</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable&#x2010;Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M (2011) SAMHD1 is the dendritic&#x2010; and myeloid&#x2010;cell&#x2010;specific HIV&#x2010;1 restriction factor counteracted by Vpx. Nature 474: 654&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595993</ArticleId><ArticleId IdType="pubmed">21613998</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhang W, Cao X (2000) Identification of human homologue of mouse IFN&#x2010;gamma induced protein from human dendritic cells. Immunol Lett 74: 221&#x2013;224</Citation><ArticleIdList><ArticleId IdType="pubmed">11064105</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Bonifati S, Qin Z, St Gelais C, Kodigepalli KM, Barrett BS, Kim SH, Antonucci JM, Ladner KJ, Buzovetsky O et&#xa0;al (2018) SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF&#x2010;kappaB and interferon pathways. Proc Natl Acad Sci USA 115: E3798&#x2013;E3807</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910870</ArticleId><ArticleId IdType="pubmed">29610295</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquel F, Silva MJ, Techer H, Zadorozhny K, Sharma S, Nieminuszczy J, Mettling C, Dardillac E, Barthe A, Schmitz AL et&#xa0;al (2018) SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature 557: 57&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">29670289</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstone DC, Ennis&#x2010;Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW et&#xa0;al (2011) HIV&#x2010;1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480: 379&#x2013;382</Citation><ArticleIdList><ArticleId IdType="pubmed">22056990</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramberg T, Kahle T, Bloch N, Wittmann S, Mullers E, Daddacha W, Hofmann H, Kim B, Lindemann D, Landau NR (2013) Restriction of diverse retroviruses by SAMHD1. Retrovirology 10: 26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605129</ArticleId><ArticleId IdType="pubmed">23497255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Li J, Xu F, Mei S, Le Duff Y, Yin L, Pang X, Cen S, Jin Q, Liang C et&#xa0;al (2015) SAMHD1 inhibits LINE&#x2010;1 retrotransposition by promoting stress granule formation. PLoS Genet 11: e1005367</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489885</ArticleId><ArticleId IdType="pubmed">26134849</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell RD, Holland PJ, Hollis T, Perrino FW (2011) Aicardi&#x2010;Goutieres syndrome gene and HIV&#x2010;1 restriction factor SAMHD1 is a dGTP&#x2010;regulated deoxynucleotide triphosphohydrolase. The Journal of biological chemistry 286: 43596&#x2013;43600</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243528</ArticleId><ArticleId IdType="pubmed">22069334</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA et&#xa0;al (2009) Mutations involved in Aicardi&#x2010;Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41: 829&#x2013;832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154505</ArticleId><ArticleId IdType="pubmed">19525956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Du J, Han X, Goodier JL, Li P, Zhou X, Wei W, Evans SL, Li L, Zhang W et&#xa0;al (2013) Modulation of LINE&#x2010;1 and Alu/SVA retrotransposition by Aicardi&#x2010;Goutieres syndrome&#x2010;related SAMHD1. Cell Rep 4: 1108&#x2013;1115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988314</ArticleId><ArticleId IdType="pubmed">24035396</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T et&#xa0;al (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13: 223&#x2013;228</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3771401</ArticleId><ArticleId IdType="pubmed">22327569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballana E, Este JA (2015) SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction. Trends Microbiol 23: 680&#x2013;692</Citation><ArticleIdList><ArticleId IdType="pubmed">26439297</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, St Gelais C, de Silva S, Yount JS, Tang C, Ji X, Shepard C, Xiong Y, Kim B, Wu L (2016) SAMHD1&#x2010;mediated HIV&#x2010;1 restriction in cells does not involve ribonuclease activity. Nat Med 22: 1072&#x2013;1074</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5069697</ArticleId><ArticleId IdType="pubmed">27711056</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloglazova N, Flick R, Tchigvintsev A, Brown G, Popovic A, Nocek B, Yakunin AF (2013) Nuclease activity of the human SAMHD1 protein implicated in the Aicardi&#x2010;Goutieres syndrome and HIV&#x2010;1 restriction. The Journal of biological chemistry 288: 8101&#x2013;8110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605629</ArticleId><ArticleId IdType="pubmed">23364794</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Ryoo J, Oh C, Hwang S, Ahn K (2015) SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology 12: 46</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450836</ArticleId><ArticleId IdType="pubmed">26032178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim SY, Seo D, Kim J, White TE, Brandariz&#x2010;Nunez A et&#xa0;al (2014) The ribonuclease activity of SAMHD1 is required for HIV&#x2010;1 restriction. Nat Med 20: 936&#x2013;941</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318684</ArticleId><ArticleId IdType="pubmed">25038827</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves A, Karayel E, Rice GI, Bennett KL, Crow YJ, Superti&#x2010;Furga G, Burckstummer T (2012) SAMHD1 is a nucleic&#x2010;acid binding protein that is mislocalized due to aicardi&#x2010;goutieres syndrome&#x2010;associated mutations. Hum Mutat 33: 1116&#x2013;1122</Citation><ArticleIdList><ArticleId IdType="pubmed">22461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Seamon KJ, Sun Z, Shlyakhtenko LS, Lyubchenko YL, Stivers JT (2015) SAMHD1 is a single&#x2010;stranded nucleic acid binding protein with no active site&#x2010;associated nuclease activity. Nucleic Acids Res 43: 6486&#x2013;6499</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4513882</ArticleId><ArticleId IdType="pubmed">26101257</ArticleId></ArticleIdList></Reference><Reference><Citation>White TE, Brandariz&#x2010;Nunez A, Valle&#x2010;Casuso JC, Amie S, Nguyen L, Kim B, Brojatsch J, Diaz&#x2010;Griffero F (2013) Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 436: 81&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767443</ArticleId><ArticleId IdType="pubmed">23158101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlcochova P, Sutherland KA, Watters SA, Bertoli C, de Bruin RA, Rehwinkel J, Neil SJ, Lenzi GM, Kim B, Khwaja A et&#xa0;al (2017) A G1&#x2010;like state allows HIV&#x2010;1 to bypass SAMHD1 restriction in macrophages. EMBO J 36: 604&#x2013;616</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5331754</ArticleId><ArticleId IdType="pubmed">28122869</ArticleId></ArticleIdList></Reference><Reference><Citation>Daddacha W, Koyen AE, Bastien AJ, Head PE, Dhere VR, Nabeta GN, Connolly EC, Werner E, Madden MZ, Daly MB et&#xa0;al (2017) SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination. Cell Rep 20: 1921&#x2013;1935</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576576</ArticleId><ArticleId IdType="pubmed">28834754</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger G, Turpin J, Cordeil S, Tartour K, Nguyen XN, Mahieux R, Cimarelli A (2012) Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. The Journal of biological chemistry 287: 41210&#x2013;41217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3510820</ArticleId><ArticleId IdType="pubmed">23076149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann H, Logue EC, Bloch N, Daddacha W, Polsky SB, Schultz ML, Kim B, Landau NR (2012) The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol 86: 12552&#x2013;12560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3497686</ArticleId><ArticleId IdType="pubmed">22973040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyei GB, Cheng X, Ramani R, Ratner L (2015) Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance. Cell Host Microbe 17: 98&#x2013;106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297224</ArticleId><ArticleId IdType="pubmed">25532805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC (2010) Antibodies mediate intracellular immunity through tripartite motif&#x2010;containing 21 (TRIM21). Proc Natl Acad Sci USA 107: 19985&#x2013;19990</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993423</ArticleId><ArticleId IdType="pubmed">21045130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakebrandt N, Lentes S, Neumann H, James LC, Neumann&#x2010;Staubitz P (2014) Antibody&#x2010; and TRIM21&#x2010;dependent intracellular restriction of Salmonella enterica . Pathogens and disease 72: 131&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">24920099</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwan WA, Mallery DL, Rhodes DA, Trowsdale J, James LC (2011) Intracellular antibody&#x2010;mediated immunity and the role of TRIM21. BioEssays: news and reviews in molecular, cellular and developmental biology 33: 803&#x2013;809</Citation><ArticleIdList><ArticleId IdType="pubmed">22006823</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC (2013) Intracellular antibody&#x2010;bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol 14: 327&#x2013;336</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672961</ArticleId><ArticleId IdType="pubmed">23455675</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YS, Yang MC, Wang B, Weissler JC (2000) Autoantigen Ro52 directly interacts with human IgG heavy chain in&#xa0;vivo in mammalian cells. Mol Immunol 37: 591&#x2013;602</Citation><ArticleIdList><ArticleId IdType="pubmed">11163395</ArticleId></ArticleIdList></Reference><Reference><Citation>James LC, Keeble AH, Khan Z, Rhodes DA, Trowsdale J (2007) Structural basis for PRYSPRY&#x2010;mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci USA 104: 6200&#x2013;6205</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1851072</ArticleId><ArticleId IdType="pubmed">17400754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes DA, Ihrke G, Reinicke AT, Malcherek G, Towey M, Isenberg DA, Trowsdale J (2002) The 52 000&#xa0;MW Ro/SS&#x2010;A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon&#x2010;gamma inducible tripartite motif protein associated with membrane proximal structures. Immunology 106: 246&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1782712</ArticleId><ArticleId IdType="pubmed">12047754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes DA, Trowsdale J (2007) TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol 44: 2406&#x2013;2414</Citation><ArticleIdList><ArticleId IdType="pubmed">17118455</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M (2017) A method for the acute and rapid degradation of endogenous proteins. Cell 171: 1692&#x2013;1706.e18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733393</ArticleId><ArticleId IdType="pubmed">29153837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottermann M, James LC (2018) Intracellular antiviral immunity. Adv Virus Res 100: 309&#x2013;354</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172442</ArticleId><ArticleId IdType="pubmed">29551141</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Dinh PX, Pattnaik AK (2015) Trim21 regulates Nmi&#x2010;IFI35 complex&#x2010;mediated inhibition of innate antiviral response. Virology 485: 383&#x2013;392</Citation><ArticleIdList><ArticleId IdType="pubmed">26342464</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Li M, Song Y, Xu W (2018) TRIM21 restricts coxsackievirus B3 replication, cardiac and pancreatic injury via interacting with MAVS and positively regulating IRF3&#x2010;mediated type&#x2010;I interferon production. Front Immunol 9: 2479</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6209670</ArticleId><ArticleId IdType="pubmed">30410495</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaysburd M, Watkinson RE, Cooper H, Reed M, O'Connell K, Smith J, Cruickshanks J, James LC (2013) Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc Natl Acad Sci USA 110: 12397&#x2013;12401</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3725055</ArticleId><ArticleId IdType="pubmed">23840060</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteeg GA, Rajsbaum R, Sanchez&#x2010;Aparicio MT, Maestre AM, Valdiviezo J, Shi M, Inn KS, Fernandez&#x2010;Sesma A, Jung J, Garcia&#x2010;Sastre A (2013) The E3&#x2010;ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern&#x2010;recognition receptors. Immunity 38: 384&#x2013;398</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3584420</ArticleId><ArticleId IdType="pubmed">23438823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu YJ (2013) The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double&#x2010;stranded DNA. Nat Immunol 14: 172&#x2013;178</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3645272</ArticleId><ArticleId IdType="pubmed">23222971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Zhu M, Pan X, Zhu Y, Yan H, Jiang T, Shen Y, Dong X, Zheng N, Lu J et&#xa0;al (2014) Inhibition of hepatitis B virus replication by SAMHD1. Biochem Biophys Res Comm 450: 1462&#x2013;1468</Citation><ArticleIdList><ArticleId IdType="pubmed">25019997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenbaugh JA, Gee P, Baker J, Daly MB, Amie SM, Tate J, Kasai N, Kanemura Y, Kim DH, Ward BM et&#xa0;al (2013) Host factor SAMHD1 restricts DNA viruses in non&#x2010;dividing myeloid cells. PLoS Pathog 9: e1003481</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3694861</ArticleId><ArticleId IdType="pubmed">23825958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ET, White TE, Brandariz&#x2010;Nunez A, Diaz&#x2010;Griffero F, Weitzman MD (2013) SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol 87: 12949&#x2013;12956</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3838123</ArticleId><ArticleId IdType="pubmed">24067963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer AF, Riviere L, Qu B, Schott K, Riess M, Ni Y, Shepard C, Schnellbacher E, Finkernagel M, Himmelsbach K et&#xa0;al (2016) Restrictive influence of SAMHD1 on hepatitis B Virus life cycle. Sci Rep 6: 26616</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882586</ArticleId><ArticleId IdType="pubmed">27229711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J (2013) Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING&#x2010;mediated apoptosis. Cell Host Microbe 14: 422&#x2013;434</Citation><ArticleIdList><ArticleId IdType="pubmed">24139400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE (2003) Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9: 78&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y, Mao S, Yang Y, Wu L, Guo X et&#xa0;al (2018) Epidemiological and serological surveillance of hand&#x2010;foot&#x2010;and&#x2010;mouth disease in Shanghai, China, 2012&#x2010;2016. Emerging microbes &amp; infections 7: 8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837173</ArticleId><ArticleId IdType="pubmed">29362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV&#x2010;1 Vpu. Nature 451: 425&#x2013;430</Citation><ArticleIdList><ArticleId IdType="pubmed">18200009</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J et&#xa0;al (2015) HIV&#x2010;1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526: 212&#x2013;217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861059</ArticleId><ArticleId IdType="pubmed">26416734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV&#x2010;1 infection and is suppressed by the viral Vif protein. Nature 418: 646&#x2013;650</Citation><ArticleIdList><ArticleId IdType="pubmed">12167863</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami Y, Wu Y, Gottlinger HG (2015) SERINC3 and SERINC5 restrict HIV&#x2010;1 infectivity and are counteracted by Nef. Nature 526: 218&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4600458</ArticleId><ArticleId IdType="pubmed">26416733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv M, Zhang B, Shi Y, Han Z, Zhang Y, Zhou Y, Zhang W, Niu J, Yu XF (2015) Identification of BST&#x2010;2/tetherin&#x2010;induced hepatitis B virus restriction and hepatocyte&#x2010;specific BST&#x2010;2 inactivation. Sci Rep 5: 11736</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4484258</ArticleId><ArticleId IdType="pubmed">26119070</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarcon&#x2010;Segovia D, Ruiz&#x2010;Arguelles A, Fishbein E (1978) Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271: 67&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">625325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes DA, Isenberg DA (2017) TRIM21 and the function of antibodies inside cells. Trends Immunol 38: 916&#x2013;926</Citation><ArticleIdList><ArticleId IdType="pubmed">28807517</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajsbaum R, Versteeg GA, Schmid S, Maestre AM, Belicha&#x2010;Villanueva A, Martinez&#x2010;Romero C, Patel JR, Morrison J, Pisanelli G, Miorin L et&#xa0;al (2014) Unanchored K48&#x2010;linked polyubiquitin synthesized by the E3&#x2010;ubiquitin ligase TRIM6 stimulates the interferon&#x2010;IKKepsilon kinase&#x2010;mediated antiviral response. Immunity 40: 880&#x2013;895</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114019</ArticleId><ArticleId IdType="pubmed">24882218</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Li H, Guo M, Wang J, Xu Y, Zou X, Deng R, Li G, Zhu H (2018) TRIM21 promotes innate immune response to RNA viral infection through Lys27&#x2010;linked polyubiquitination of MAVS. J Virol 92: e00321&#x2010;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6026736</ArticleId><ArticleId IdType="pubmed">29743353</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana FJ, Sjostrand M, Eloranta ML, Ni Gabhann J, Winqvist O et&#xa0;al (2009) Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL&#x2010;23&#x2010;Th17 pathway. J Exp Med 206: 1661&#x2013;1671</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722164</ArticleId><ArticleId IdType="pubmed">19635858</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Dong C, Li X, Gao Q, Guo Z, Yao X, Wang Y, Gao F, Li F, Xu M et&#xa0;al (2012) Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS ONE 7: e46043</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460965</ArticleId><ArticleId IdType="pubmed">23029378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Gao F, Mao Q, Shao J, Jiang L, Liu D, Wang Y, Yao X, Wu X, Sun B et&#xa0;al (2015) Immunogenicity and protective efficacy of an EV71 virus&#x2010;like particle vaccine against lethal challenge in newborn mice. Hum Vaccin Immunother 11: 2406&#x2013;2413</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635907</ArticleId><ArticleId IdType="pubmed">26036916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Li J, Liu X, Liu G, Yang J, Wei W, Zhang W, Yu XF (2015) Broad protection with an inactivated vaccine against primary&#x2010;isolated lethal enterovirus 71 infection in newborn mice. BMC Microbiol 15: 139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501189</ArticleId><ArticleId IdType="pubmed">26169371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Wu J, Du F, Chen X, Chen ZJ (2013) Cyclic GMP&#x2010;AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786&#x2013;791</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863629</ArticleId><ArticleId IdType="pubmed">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada K, Kamitani T (2006) Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Comm 339: 415&#x2013;421</Citation><ArticleIdList><ArticleId IdType="pubmed">16297862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Huang M, Wang T, Tan L, Tian C, Yu X, Kong W, Yu XF (2008) Conserved and non&#x2010;conserved features of HIV&#x2010;1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases. Cell Microbiol 10: 1662&#x2013;1675</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086741</ArticleId><ArticleId IdType="pubmed">18419775</ArticleId></ArticleIdList></Reference><Reference><Citation>White TE, Brandariz&#x2010;Nunez A, Valle&#x2010;Casuso JC, Amie S, Nguyen LA, Kim B, Tuzova M, Diaz&#x2010;Griffero F (2013) The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 13: 441&#x2013;451</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3864637</ArticleId><ArticleId IdType="pubmed">23601106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Gao W, Zhao K, Qin X, Zhang Y, Peng X, Zhang L, Dong Y, Zhang W, Li P et&#xa0;al (2013) Structural insight into dGTP&#x2010;dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. Nat Commun 4: 2722</Citation><ArticleIdList><ArticleId IdType="pubmed">24217394</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, Sun Y, Jiang YP, Bott AJ, Jaber N, Dou Z, Yang B, Chen JS, Catanzaro JM, Du C et&#xa0;al (2016) TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell 61: 720&#x2013;733</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779181</ArticleId><ArticleId IdType="pubmed">26942676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cribier A, Descours B, Valadao AL, Laguette N, Benkirane M (2013) Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV&#x2010;1. Cell Rep 3: 1036&#x2013;1043</Citation><ArticleIdList><ArticleId IdType="pubmed">23602554</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, St Gelais C, Wu L (2017) The dynamic interplay between HIV&#x2010;1, SAMHD1, and the innate antiviral response. Front Immunol 8: 1541</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5686096</ArticleId><ArticleId IdType="pubmed">29176984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauney CH, Hollis T (2018) SAMHD1: recurring roles in cell cycle, viral restriction, cancer, and innate immunity. Autoimmunity 51: 96&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6117824</ArticleId><ArticleId IdType="pubmed">29583030</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow YJ, Rehwinkel J (2009) Aicardi&#x2010;Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18: R130&#x2013;R136</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758706</ArticleId><ArticleId IdType="pubmed">19808788</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello&#x2010;Lobato MJ, Wang S, Schmidt CK (2017) SAMHD1 sheds moonlight on DNA double&#x2010;strand break repair. Trends in genetics : TIG 33: 895&#x2013;897</Citation><ArticleIdList><ArticleId IdType="pubmed">28969870</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, Kim SH, St Gelais C, Bonifati S, Li TW, Buzovetsky O, Knecht KM, Duchon AA, Xiong Y, Musier&#x2010;Forsyth K et&#xa0;al (2018) SAMHD1 impairs HIV&#x2010;1 gene expression and negatively modulates reactivation of viral latency in CD4(+) T cells. J Virol 92: e00292&#x2010;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052313</ArticleId><ArticleId IdType="pubmed">29793958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Du J, Evans SL, Yu Y, Yu XF (2011) T&#x2010;cell differentiation factor CBF&#x2010;beta regulates HIV&#x2010;1 Vif&#x2010;mediated evasion of host restriction. Nature 481: 376&#x2013;379</Citation><ArticleIdList><ArticleId IdType="pubmed">22190036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo H, Su J, Rui Y, Zheng W, Gao W, Zhang W, Li Z, Liu G, Markham RB et&#xa0;al (2017) Inhibition of Vpx&#x2010;mediated SAMHD1 and Vpr&#x2010;mediated host helicase transcription factor degradation by selective disruption of viral CRL4 (DCAF1) E3 ubiquitin ligase assembly. J Virol 91: e00225&#x2010;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391453</ArticleId><ArticleId IdType="pubmed">28202763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Gao Q, Markham R, Yu XF (2014) Variation of two primate lineage&#x2010;specific residues in human SAMHD1 confers resistance to N terminus&#x2010;targeted SIV Vpx proteins. J Virol 88: 583&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911740</ArticleId><ArticleId IdType="pubmed">24173216</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ning S, Su X, Liu X, Wang H, Liu Y, Zheng W, Zheng B, Yu XF, Zhang W (2018) Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G. Nucleic Acids Res 46: 11514&#x2013;11527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265463</ArticleId><ArticleId IdType="pubmed">30247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chang J, Liu X, Yang J, Guo H, Wei W, Zhang W, Yu XF (2014) Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J Gen Virol 95: 1083&#x2013;1093</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983757</ArticleId><ArticleId IdType="pubmed">24496826</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>